Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tafamidis meglumine 20mg capsules
0409030S0AAAAAA
|
Tafamadis meglumine (old) | Tafamidis meglumine (old) | Central Nervous System | No data available |
|
Tafinlar 50mg capsules
0801050CUBBAAAA
|
Tafinlar | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Tafinlar 75mg capsules
0801050CUBBABAB
|
Tafinlar | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Taflotan 15micrograms/ml eye drops
1106000AKBCAAAB
|
Taflotan | Tafluprost | Eye | No data available |
|
Tagadine 400mg tablets
0103010D0BMAAAB
|
Tagadine | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 100 tablets
0103010D0BBAIAK
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg tablets
0103010D0BBAAAA
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg/2ml solution for injection ampoules
0103010D0BBAEAE
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 400mg effervescent tablets
0103010D0BBAGAI
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 800mg tablets
0103010D0BBACAC
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagrisso 40mg tablets
0801050CGBBAAAA
|
Tagrisso | Osimertinib | Malignant Disease and Immunosuppression | No data available |
|
Tagrisso 80mg tablets
0801050CGBBABAB
|
Tagrisso | Osimertinib | Malignant Disease and Immunosuppression | No data available |
|
Talidex 25mg tablets
0501100J0BCAAAJ
|
Talidex | Thalidomide (Antileprotic) | Infections | No data available |
|
Talmanco 20mg tablets
0704050R0BDAAAB
|
Talmanco | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Taltz 80mg/1ml solution for injection pre-filled pens
1305030G0BBABAB
|
Taltz | Ixekizumab | Skin | No data available |
|
Taltz 80mg/1ml solution for injection pre-filled syringes
1305030G0BBAAAA
|
Taltz | Ixekizumab | Skin | No data available |
|
Tambocor 150mg/15ml solution for injection ampoules
0203020I0BBABAA
|
Tambocor | Flecainide acetate | Cardiovascular System | No data available |
|
Tambocor XL 200mg capsules
0203020I0BBADBQ
|
Tambocor | Flecainide acetate | Cardiovascular System | No data available |
|
Tamiflu 12mg/ml oral suspension
0503040B0BBABAB
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
|
Tamiflu 45mg capsules
0503040B0BBADAD
|
Tamiflu | Oseltamivir phosphate | Infections | No data available |
|
Tamofen 10 tablets
0803041S0BFAAAA
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamofen 20 tablets
0803041S0BFABAB
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamofen 40 tablets
0803041S0BFACAC
|
Tamofen | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 10mg/5ml oral liquid
0803041S0AAAHAH
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Tamoxifen 20mg/5ml oral liquid
0803041S0AAAGAG
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.